Bridgewest Ventures has announced a significant milestone for New Zealand's technology sector, successfully completing the first close of its inaugural fund at US$32 million. This initial capital raise for Bridgewest Ventures Fund I LP drew substantial commitments from a diverse group of over 20 domestic investors. The achievement underscores strong local confidence in the nation's burgeoning deep technology and life sciences industries.
Strong Domestic Backing and Future Ambitions
The fund's initial success is largely attributed to strong support from within New Zealand, including institutional investors, family offices, and high-net-worth individuals. A key component of this backing came from migrant investors participating through the Active Investor Plus programme. With this solid foundation, Bridgewest Ventures will now expand its capital-raising efforts internationally to attract offshore investment.
While the first close surpassed initial targets, the fund is ultimately aiming for a total capital raise of $158 million. It possesses the structural capacity to deploy up to $115.5 million should compelling opportunities arise in the market. The capital raise will remain open to new investors through the fourth quarter of 2026, providing ample time to reach its goal.
A Strategic Bridge for Global Expansion
Bridgewest Ventures offers more than just financial backing, acting as a strategic partner for its portfolio companies. The firm leverages the extensive global network of its parent company, the U.S.-based Bridgewest Group, which has a 25-year history of venture creation. This connection provides New Zealand startups with invaluable access to international markets, expertise, and commercial infrastructure.
As an approved partner under Callaghan Innovation's Technology Incubator Programme, the firm is committed to fostering local entrepreneurship. Its model focuses on providing mentorship and operational support to help commercialize innovative technologies and improve business capabilities. This hands-on approach is designed to build startups into globally competitive companies while strengthening the local ecosystem.
Fostering New Zealand's Deep Tech Ecosystem
The fund specifically targets high-growth New Zealand companies in sectors such as life sciences, medical technology, advanced materials, and artificial intelligence. Chief Executive Officer Saum Vahdat expressed his satisfaction with the strong support, noting that New Zealand produces world-class innovation. He emphasized the firm's role in building a bridge between international capital and high-impact local ventures.
This strategic investment is intended to generate significant economic benefits that remain within the country. The firm aims to hyper-scale its portfolio companies, ensuring the creation of high-value jobs and the retention of world-class intellectual property on home soil. This focus supports the long-term goal of strengthening New Zealand's export growth and global competitiveness.
The successful $32 million first close of Bridgewest Ventures Fund I marks a pivotal moment for New Zealand's innovation landscape. It serves as a powerful vote of confidence from local investors in the potential of the nation's deep tech and life sciences sectors. As the fund expands its reach internationally, it is well-positioned to accelerate the global growth of homegrown technology.